Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study

BACKGROUND AND AIMS: The ProCID study evaluated the efficacy and safety of three doses of a 10% liquid intravenous immunoglobulin (IVIg) preparation (panzyga(®)) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). This report describes the safety findings. METHODS: Patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornblath, David R., van Doorn, Pieter A., Hartung, Hans-Peter, Merkies, Ingemar S. J., Katzberg, Hans D., Hinterberger, Doris, Clodi, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442284/
https://www.ncbi.nlm.nih.gov/pubmed/37378806
http://dx.doi.org/10.1007/s40264-023-01326-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442284/
https://www.ncbi.nlm.nih.gov/pubmed/37378806
http://dx.doi.org/10.1007/s40264-023-01326-z

Ejemplares similares